pKi: 8.0 (human OX2R), 8.1 (rat OX2R)[1]
[1]. Bonaventure P, et al. Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of Insomnia. J Pharmacol Exp Ther. 2015 Sep;354(3):471-82.
上海德欣致远生物技术有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
朱经理